Handelsbanken Fonder’s Agilon Health AGL Stock Holding History

Handelsbanken Fonder’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,404	Closed	-$36K	–	1497
2025 Q3	$36K	Hold	1,404	–	–	﹤0.01%	1499
2025 Q2	$81K	Sell	1,404 -1,596	-53%	-$128K	﹤0.01%	1512
2025 Q1	$325K	Hold	3,000	–	–	﹤0.01%	1380
2024 Q4	$142K	Buy	3,000 +972	+48%	+$58.8K	﹤0.01%	1531
2024 Q3	$199K	Hold	2,028	–	–	﹤0.01%	1494
2024 Q2	$332K	Buy	2,028 +348	+21%	+$49.6K	﹤0.01%	1342
2024 Q1	$256K	Hold	1,680	–	–	﹤0.01%	1435
2023 Q4	$527K	Hold	1,680	–	–	﹤0.01%	1120
2023 Q3	$746K	Buy	1,680 +376	+29%	+$170K	﹤0.01%	855
2023 Q2	$565K	Buy	1,304 +8	+0.6%	+$4.5K	﹤0.01%	1002
2023 Q1	$770K	Buy	1,296 +316	+32%	+$177K	﹤0.01%	793
2022 Q4	$395K	Buy	980 +8	+0.8%	+$3.75K	﹤0.01%	1087
2022 Q3	$569K	Hold	972	–	–	﹤0.01%	888
2022 Q2	$530K	Buy	972 +20	+2%	+$10.1K	﹤0.01%	991
2022 Q1	$603K	Sell	952 -228	-19%	-$118K	﹤0.01%	1069
2021 Q4	$796K	Buy	+1,180	New	+$718K	﹤0.01%	1025

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NPCM

North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Handelsbanken Fonder's AGL Position: Q4 2025 in Review

Handelsbanken Fonder sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 1,404 shares — an estimated $36K sold.

Handelsbanken Fonder first reported a position in AGL in Q4 2021 and held it in 16 quarters. The position peaked at $796K in Q4 2021. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

Handelsbanken Fonder reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
Handelsbanken Fonder sold 1,404 Agilon Health shares in Q4 2025, an estimated $36K.
Handelsbanken Fonder first reported a position in Agilon Health in Q4 2021 and held it in 16 quarters.
Handelsbanken Fonder's Agilon Health position peaked at $796K in Q4 2021.
194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Handelsbanken Fonder's 13F filing for Q4 2025, filed 6 Feb 2026.